This course reviews the pivotal updates and refined recommendations featured in the American Diabetes Association (ADA) 2026 Standards of Care. Clinicians will examine expanded guidelines for continuous glucose monitoring (CGM), streamlined access to automated insulin delivery (AID) technologies, and enhanced risk-stratification models for type 1 diabetes. The curriculum also covers specialized protocols for managing hyperglycemia in oncology patients, emphasizing a modern, technology-supported framework to optimize both glycemic control and long-term cardiometabolic health.